Get started
ALLIANCE PHARMA PLCALLIANCE PHARMA PLCALLIANCE PHARMA PLC

ALLIANCE PHARMA PLC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

DVL chart


Full chart

DVL upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪300.73 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.07 EUR
Net income (FY)
‪−38.22 M‬ EUR
Revenue (FY)
‪208.39 M‬ EUR
Shares float
‪389.70 M‬
Beta (1Y)
1.06

Employees


Employees (FY)
292
Change (1Y)
+7 +2.46%
Revenue / Employee (1Y)
‪713.66 K‬ EUR
Net income / Employee (1Y)
‪−130.88 K‬ EUR

About ALLIANCE PHARMA PLC


Sector
Health Technology
CEO
Nick Sedgwick
Headquarters
Chippenham
Website
alliancepharma.co.uk
Founded
2001
ISIN
GB0031030819
FIGI
BBG000QY2V23
Alliance Pharma Plc is a holding company, which engages in the provision of acquisition, marketing, and distribution of healthcare and pharmaceutical products. It holds marketing rights to a range of healthcare brands and prescription medicines. The company was founded by John Dawson in 1996 and is headquartered in Chippenham, the United Kingdom.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

DVL news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of DVL is 0.54 EUR — it has decreased by −0.92% in the past 24 hours. Watch ALLIANCE PHARMA PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ALLIANCE PHARMA PLC stocks are traded under the ticker DVL.
DVL stock has fallen by −6.09% compared to the previous week, the month change is a 2.86% rise, over the last year ALLIANCE PHARMA PLC has showed a 23.29% increase.
We've gathered analysts' opinions on ALLIANCE PHARMA PLC future price: according to them, DVL price has a max estimate of 1.03 EUR and a min estimate of 0.51 EUR. Watch DVL chart and read a more detailed ALLIANCE PHARMA PLC stock forecast: see what analysts think of ALLIANCE PHARMA PLC and suggest that you do with its stocks.
DVL reached its all-time high on Mar 29, 2022 with the price of 1.49 EUR, and its all-time low was 0.30 EUR and was reached on May 8, 2024. View more price dynamics on DVL chart.
See other stocks reaching their highest and lowest prices.
DVL stock is 0.93% volatile and has beta coefficient of 1.06. Track ALLIANCE PHARMA PLC stock price on the chart and check out the list of the most volatile stocks — is ALLIANCE PHARMA PLC there?
Today ALLIANCE PHARMA PLC has the market capitalization of ‪300.73 M‬, it has decreased by −2.55% over the last week.
Yes, you can track ALLIANCE PHARMA PLC financials in yearly and quarterly reports right on TradingView.
ALLIANCE PHARMA PLC is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
ALLIANCE PHARMA PLC revenue for the last half-year amounts to ‪100.09 M‬ EUR, despite the estimated figure of ‪100.09 M‬ EUR. In the next half-year revenue is expected to reach ‪124.18 M‬ EUR.
DVL net income for the last half-year is ‪5.50 M‬ EUR, while the previous report showed ‪−44.11 M‬ EUR of net income which accounts for 112.48% change. Track more ALLIANCE PHARMA PLC financial stats to get the full picture.
As of Dec 23, 2024, the company has 292.00 employees. See our rating of the largest employees — is ALLIANCE PHARMA PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALLIANCE PHARMA PLC EBITDA is ‪60.44 M‬ EUR, and current EBITDA margin is 24.90%. See more stats in ALLIANCE PHARMA PLC financial statements.
Like other stocks, DVL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALLIANCE PHARMA PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALLIANCE PHARMA PLC technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALLIANCE PHARMA PLC stock shows the neutral signal. See more of ALLIANCE PHARMA PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.